The VISICORT study “TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung” was published online in the FASEB Journal on May 20, 2019. The authors of the study from NUI Galway are Nick Murphy, Oliver Treacy, Kevin Lynch, Maurice Morcos, Paul Lohan, Linda Howard, Gerry Fahy, Matthew D. Griffin, Aideen E. Ryan, and Thomas Ritter.
Congratulations to the VISICORT team!
Read more of the story here.
Learn more about VISICORT at www.visicort.eu, on Twitter @visicort and on Facebook https://www.facebook.com/visicort/. You can also find information on LinkedIn and Research Gate.
VISICORT has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.